You have read all your free articles, to continue reading subscribe to read the rest of this content.
Dr. Johan Luthman has been appointed Executive Vice President and Head of Research & Development in Lundbeck. Luthman will assume his new role and join the Executive Management on 1 March 2019 and brings approximately 28 years of experience in pharmaceutical R&D. He has been exposed to R&Already a subscriber…
Recipharm AB announces that it has entered into an agreement to acquire Italian CDMO, Mitim Srl adding scale and capabilities to the group. Mitim is currently owned by a private Italian family and is specialised in the filling of injectable beta lactam products. It is located in Brescia close toAlready a subscriber Login You…
The U.S. Food and Drug Administration (FDA) has approved the use of Genmab's DARZALEX (daratumumab) in combination with lenalidomide and dexamethasone, or bortezomib and dexamethasone, for the treatment of patients with multiple myeloma who have received at least one prior therapy. In July 2016, Already a subscriber Login You have…
AstraZeneca will open a new manufacturing and packaging facility in Kaluga, Russia, dedicated to the local supply of innovative medicines. In 2011 AstraZeneca was one of the first multinational pharmaceutical companies to announce plans to invest in the construction of a dedicated manufacturing fAlready a subscriber Login You have read…
